---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-22-042873"
form_type: "8-K"
ticker: "ANGO"
cik: "0001275187"
company_name: "ANGIODYNAMICS INC"
filed_at: "2022-11-23T23:59:59+00:00"
generated_at: "2026-06-21T13:19:37.238746+00:00"
event_type: "litigation"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# AngioDynamics loses patent infringement jury verdict to Bard on port products

## Summary
- Jury verdict found AngioDynamics' implantable port products infringe certain Bard patents (Nov 22, 2022).
- Damages were bifurcated and not determined by jury; separate proceeding required.
- Company strongly disagrees with verdict, believes it is unsupported, and plans post-trial motions and appeals.
- Equitable issues and patent eligibility issues remain to be decided by the judge.

## SEC filing metadata
- accession: 0001140361-22-042873
- form_type: 8-K
- ticker: ANGO
- cik: 0001275187
- company_name: ANGIODYNAMICS INC
- filed_at: 2022-11-23T23:59:59+00:00
- event_type: litigation
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1275187/000114036122042873/0001140361-22-042873-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1275187/000114036122042873/brhc10044627_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-22-042873
- JSON: https://secwatch.observer/filing/0001140361-22-042873.json
- Plain text: https://secwatch.observer/filing/0001140361-22-042873.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.